Veralox Therapeutics
Location: United States, Maryland, Frederick
Employees: 11-50
Total raised: $22M
Founded date: 2018
Investors 4
| Date | Name | Website |
| - | Maryland M... | momentum.u... |
| - | NYBC Ventu... | nybcventur... |
| - | VTC Innova... | vtcventure... |
| 30.01.2022 | Genesys Ca... | genesyscap... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 23.06.2021 | Series A | $16.6M | - |
| 05.09.2019 | Seed | $5.4M | - |
Mentions in press and media 16
| Date | Title | Description |
| 07.09.2022 | University System of Maryland Names Mike Ravenscroft Managing Director of the Maryland Momentum Fund | Baltimore, Md. (Sept. 7, 2022) – The University System of Maryland (USM) has named Mike Ravenscroft as Managing Director of the Maryland Momentum Fund (MMF), a $16 million investment fund that supports early stage companies affiliated with ... |
| 03.02.2022 | Small businesses are facing challenges right now. Maryland Tech Council is using its network of advisers to help them thrive | Gaithersburg-based EzBiome was struggling with one of the most prevalent issues that businesses are facing in the pandemic — hiring new staff. That is, until the microbial identification and microbiome sequencing company reached out last ye... |
| 02.07.2021 | Viewpoint: Md. startups are poised for takeoff, but the entrepreneurial ecosystem is still in its infancy | After leading the University System of Maryland Maryland Momentum Fund for nearly two years — performing due diligence on over 250 companies and making 22 investments and counting — I’m able to offer a full picture on Maryland’s strengths a... |
| 25.06.2021 | Power Moves: Kerrie Carden on joining INVANTI as chief revenue officer, and remote work tips | Power Moves is a column where we chart the comings and goings of talent across the region, and other people-oriented updates. Got a new hire, new gig or promotion? Tell us: baltimore@technical.ly.INVANTI is a company with a mission that sou... |
| 23.06.2021 | USM Maryland Momentum Fund Portfolio Company Veralox Therapeutics Announces $16 Million in New Investment | Company Led by University of Maryland Graduate Jeff Strovel Shows Continued Growth after Receiving Seed Funding from Maryland Momentum Fund and Other Investors in 2019 |
| 23.06.2021 | Money Moves: It’s a big investment week for Frederick companies | This week, a pair of Frederick companies raised millions in new investment, offering evidence of the Maryland city’s growing role as one of the region’s tech hubs. Check out the specifics on those companies and more:Vita Therapeutics raised... |
| 16.06.2021 | Veralox Therapeutics Closes $16.6M Series A Financing | Veralox Therapeutics, a Frederick, Md.-based biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, closed a $16.6m Series A financ... |
| 27.01.2021 | Veralox Therapeutics Announces FDA Orphan Drug Designation for VLX-1005 | “This is a significant regulatory milestone for our company, and in the development of this investigational new drug product and recognition of the clear unmet medical need for patients who suffer from this devastating disease.” - Jeffrey W... |
| 14.01.2021 | Veralox Therapeutics Announces IND Submission for VLX-1005 to Treat Heparin-Inducted Thrombocytopenia | “This IND submission is a key milestone for Veralox and a tribute to the hard work and dedication of our team to advance VLX-1005 to first in human studies.” - Jeffrey Strovel, Ph.D., CEO, Veralox Therapeutics, Inc. FREDERICK, Md. (PRWEB) J... |
| 14.01.2021 | Veralox Therapeutics Announces IND Submission for VLX-1005 to Treat Heparin-Inducted Thrombocytopenia | FREDERICK, Md.--(BUSINESS WIRE)--Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced it ... |
Show more